Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Kaye

Showing results (41-50 of 853) with videos related to

Pageof 86
Sort By:
The American Journal of Medicine|December 29, 1995
Clinical drug resistance: the role of factors other than P-glycoproteinS B Kaye
Current Oncology Reports|April 9, 2002
Combination chemotherapy for ovarian cancer--lessons not yet learned?Stanley B Kaye
Scottish Medical Journal|July 1, 1983
Whither lung cancer treatment in 1983?S B Kaye
Postgraduate Medicine|December 9, 2017
Thyroid function testsTodd B Kaye
Postgraduate Medicine|December 9, 2017
HypercalcemiaTodd B Kaye
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 21, 2007
Bevacizumab for the treatment of epithelial ovarian cancer: will this be its finest hour?Stanley B Kaye
Clinical Advances in Hematology & Oncology : H&O|March 19, 2008
New drugs for ovarian cancerStanley B Kaye
Current Opinion in Oncology|November 5, 1998
Multidrug resistance: clinical relevance in solid tumours and strategies for circumventionS B Kaye
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 4, 2016
Progress in the treatment of ovarian cancer-lessons from homologous recombination deficiency-the first 10 yearsS B Kaye
American Journal of Ophthalmology|August 10, 2005
Testing distance stereoacuity with the Frisby-Davis 2 (FD2) testStephen B Kaye
Pageof 86

Showing results (41-50 of 853) with videos related to

Sort By:
Pageof 86
The American Journal of Medicine|December 29, 1995
Clinical drug resistance: the role of factors other than P-glycoproteinS B Kaye
Current Oncology Reports|April 9, 2002
Combination chemotherapy for ovarian cancer--lessons not yet learned?Stanley B Kaye
Scottish Medical Journal|July 1, 1983
Whither lung cancer treatment in 1983?S B Kaye
Postgraduate Medicine|December 9, 2017
Thyroid function testsTodd B Kaye
Postgraduate Medicine|December 9, 2017
HypercalcemiaTodd B Kaye
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 21, 2007
Bevacizumab for the treatment of epithelial ovarian cancer: will this be its finest hour?Stanley B Kaye
Clinical Advances in Hematology & Oncology : H&O|March 19, 2008
New drugs for ovarian cancerStanley B Kaye
Current Opinion in Oncology|November 5, 1998
Multidrug resistance: clinical relevance in solid tumours and strategies for circumventionS B Kaye
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 4, 2016
Progress in the treatment of ovarian cancer-lessons from homologous recombination deficiency-the first 10 yearsS B Kaye
American Journal of Ophthalmology|August 10, 2005
Testing distance stereoacuity with the Frisby-Davis 2 (FD2) testStephen B Kaye
Pageof 86